Author(s): Salgado ME, Sutor B, Albright RC Jr, Frye MA
Abstract Share this page
Abstract Lithium as a gold standard therapy for bipolar disorder is well known to have a number of medical comorbidities that impact renal, parathyroid, and thyroid function. Despite these medical comorbidities, there remains a group of lithium-responsive lithium-treated patients who have maintained mood stability for decades. The risk/benefit ratio of end organ toxicity/mood stability must be evaluated in each individual case.
This article was published in Int J Bipolar Disord
and referenced in Journal of Sleep Disorders & Therapy